ReviewProbiotics and antimicrobial proteins2026
Bacillaceae in Probiotics and Postbiotics: Applications, Functional Traits, Mechanisms and Outlook.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of Indigenous Bacillus Strains from Asian Fermented Foods for Probiotic Properties.Probiotics and antimicrobial proteins · 2026Article
- Comparative evaluation of Saccharomyces, Bacillus, and Lactobacillus as antibiotic alternatives on growth performance, redox balance, and gut microbiota in broilers.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Despite the well-documented health benefits of non-spore-forming probiotics such as Lactobacillus and Bifidobacterium, their broader application can be constrained by limited stability and survivability during processing, storage and gastrointestinal transit. These limitations have driven growing interest in spore-forming bacteria belonging to Bacillaceae family for potential use as probiotics particularly for products that require heat processing or extended shelf-life. This review focuses on the genera Bacillus, Heyndrickxia and Priestia, which have established roles across biotechnology, food and industrial applications, with evidence demonstrating benefits in plants, animals and human nutrition. Key technological traits, carbohydrates and nitrogen metabolism capacities and bioactive outputs are highlighted in this review, including the production of enzymes, antimicrobial compounds such as bacteriocins and non-ribosomal synthesized peptides, as well as other metabolites relevant to host and microbiome modulation. The mechanistic basis underpinning reported functions, such as competitive exclusions, antimicrobial activity, and immunomodulatory effect are also discussed in the context of probiotic and postbiotic. Finally, translational considerations, challenges and outlook in spore-forming probiotic and postbiotic biosolutions are addressed, including strain specific efficacy, safety evaluation and long-term use, and the practical requirements for robust human validation. This review intends to provide a critical and comprehensive synthesis, to update and further encourage researchers and industry stakeholders in developing Bacillaceae-based probiotics and postbiotics that align with the market needs.
Indexed as
Identifiers
42217154What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.